The Philippine healthcare industry has long faced obstacles in accessibility, exacerbated by the global health crisis. The coronavirus pandemic has highlighted the disparities in healthcare services, such as insufficient facilities and the need for improved skills among healthcare workers. Recognizing these challenges, Singapore Diagnostics (SGD) has stepped up to address these pain points, bringing world-class services and training closer to Filipinos.

VisayasMed Hospital has taken a giant leap in advancing healthcare in the Visayas and Mindanao regions by launching a state-of-the-art medical laboratory in collaboration with Singapore Diagnostics (SGD).

In the world of healthcare, accurate diagnosis is the key to effective treatment. A wrong diagnosis can have devastating effects, making reliable lab testing critical for patient care. Singapore Diagnostics (SGD) is committed to delivering world-class diagnostic services that ensure Filipinos receive accurate, affordable, and timely results.

Singapore Diagnostics (SGD) triumphed at the Healthcare Asia Awards 2025, held on April 10, winning three prestigious awards. The company was named Diagnostics Provider of the Year for the third consecutive time, along with winning Facilities Improvement Initiative of the Year and ICT Initiative of the Year.

Singapore Diagnostics (SGD), the Philippine flagship of Singapore-based Pathology Asia, has been recognized as a consistent healthcare leader, earning eight major national and regional awards from 2023 to 2025. These accolades highlight the company’s commitment to innovation, quality service, and affordable diagnostics for Filipinos.

Singapore Diagnostics (SGD) won the ICT Initiative of the Year at the Healthcare Asia Awards 2025 for its innovative e-SLIP platform. The award highlights SGD’s leadership in healthcare technology and its commitment to improving laboratory integration across the Philippines.